XML 19 R9.htm IDEA: XBRL DOCUMENT v3.25.3

NET SALES

9 Months Ended

Sep. 30, 2025

Revenue from Contract with Customer [Abstract]

NET SALES

NOTE 3. NET SALES

Revenue Recognition

Revenue under contract manufacturing agreements that was recognized over time, excluding noncash consideration, accounted for 75% of net sales for both the three and nine months ended September 30, 2025 and 72% and 73% of net sales for the three and nine months ended September 30, 2024, respectively.

The following tables summarize our net sales by market for the three and nine months ended September 30, 2025 and 2024, respectively:

 SCHEDULE OF NET SALES BY MARKET 

		Product/ Service Transferred Over Time				Product Transferred at Point in Time				Noncash Consideration1				Total Net Sales by Market
		Three Months Ended September 30, 2025
		Product/ Service Transferred Over Time				Product Transferred at Point in Time				Noncash Consideration1				Total Net Sales by Market
Medical Device		$	5,758			$	2,004			$	589			$	8,351
Medical Imaging			8,215				2,169				5				10,389
Industrial			6,163				1,798				251				8,212
Aerospace and Defense			2,576				886				68				3,530
Total net sales		$	22,712			$	6,857			$	913			$	30,482

		Product/ Service Transferred Over Time				Product Transferred at Point in Time				Noncash Consideration1				Total Net Sales by Market
		Three Months Ended September 30, 2024
		Product/ Service Transferred Over Time				Product Transferred at Point in Time				Noncash Consideration1				Total Net Sales by Market
Medical Device(2)		$	5,505			$	2,087			$	898			$	8,490
Medical Imaging(2)			7,206				2,348				3				9,557
Industrial			5,505				2,667				262				8,434
Aerospace and Defense			4,394				494				38				4,926
Total net sales		$	22,610			$	7,596			$	1,201			$	31,407

		Product/ Service Transferred Over Time				Product Transferred at Point in Time				Noncash Consideration1				Total Net Sales by Market
		Nine Months Ended September 30, 2025
		Product/ Service Transferred Over Time				Product Transferred at Point in Time				Noncash Consideration1				Total Net Sales by Market
Medical Device		$	16,579			$	5,738			$	1,654			$	23,971
Medical Imaging			22,413				6,211				17				28,641
Industrial			17,459				5,729				485				23,673
Aerospace and Defense			9,333				2,250				184				11,767
Total net sales		$	65,784			$	19,928			$	2,340			$	88,052

		Product/ Service Transferred Over Time				Product Transferred at Point in Time				Noncash Consideration1				Total Net Sales by Market
		Nine Months Ended September 30, 2024
		Product/ Service Transferred Over Time				Product Transferred at Point in Time				Noncash Consideration1				Total Net Sales by Market
Medical Device(2)		$	17,178			$	6,919			$	2,396			$	26,493
Medical Imaging(2)			20,291				7,193				14				27,498
Industrial			18,847				7,682				1,114				27,643
Aerospace and Defense			16,494				1,231				154				17,879
Total net sales		$	72,810			$	23,025			$	3,678			$	99,513

1	Noncash consideration represents material provided by the customer used in the manufacturing of the product.
2	Medical, as reported in the prior-year period filing, has been split between Medical Device and Medical Imaging to conform with the current-year presentation.

Contract Assets

Contract assets, recorded in the condensed consolidated balance sheets, consist of unbilled amounts related to revenue recognized over time. Significant changes in the contract assets balance during the nine months ended September 30, 2025 were as follows:

 SCHEDULE OF CONTRACT ASSETS 

Balance as of December 31, 2024		$	13,792
Increase (decrease) attributed to:
Amounts transferred over time to contract assets			65,784
Allowance for current expected credit losses			(1	)
Amounts invoiced during the period			(64,247	)
Balance outstanding as of September 30, 2025		$	15,328

We expect substantially all the remaining performance obligations for the contract assets recorded as of September 30, 2025 to be transferred to receivables within 90 days, with any remaining amounts to be transferred within 180 days. We bill our customers upon shipment with payment terms of up to 120 days.

X

- References

No definition available.

+ Details

Name:	us-gaap_RevenueFromContractWithCustomerAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 7
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479806/606-10-50-7

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 9
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479806/606-10-50-9

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 10
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479806/606-10-50-10

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 15
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479806/606-10-50-15

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 12
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479806/606-10-50-12

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 12
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479806/606-10-50-12

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 12
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479806/606-10-50-12

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 12
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479806/606-10-50-12

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 12
-Subparagraph (e)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479806/606-10-50-12

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 13
-Subparagraph (b)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479806/606-10-50-13

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Name Accounting Standards Codification
-Topic 606
-Publisher FASB
-URI https://asc.fasb.org/606/tableOfContent

+ Details

Name:	us-gaap_RevenueFromContractWithCustomerTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration